Potential of transfusion therapy in surgical practice in patients with liver cirrhosis (review of the literature)
https://doi.org/10.24884/0042-4625-2019-178-4-76-80
Abstract
Currently, there are no clear indications for transfusion therapy in patients with liver cirrhosis. The article describes in detail the main clinical syndromes and pathophysiological mechanisms of chronic hepatitis, including the outcome of cirrhosis of the liver against the background of endotoxemia. The authors paid attention to the justification of the potential of transfusion therapy in this category of patients.
About the Authors
E. Iu. Lazareva
Clinical infectious diseases hospital named after S. P. Botkin
Russian Federation
Russian Federation
49 Piskarevskii street, St. Petersburg, Russia, 195067
A. V. Koloskov
North-Western State Medical University named after I. I. Mechnikov
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
References
1. Мikurov A. A., Garbuzenko D. V. Sravnitel’nyy analiz urovnya endotoksemii u bol’nykh tsirrozom pecheni s portal’noy gipertenziyey. Fundamental’nyye issledovaniya. 2011;(6):126–128. (In Russ.).
2. Kuznetsov P. L., Borzunov V. M. Sindrom endogennoy intoksikatsii v patogeneze virusnogo gepatita. Eksperimental’naya i klinicheskaya gastroenterologiya. 2013;(4):44–50. (In Russ.).
3. Kotiv B. N., Dzidzava I. I., Kashkin D. P. et al. Lecheniye i profilaktika krovotecheniy iz varikozno rasshirennykh ven u bol’nykh tsirrozom pecheni s sindromom portal’noy gipertenzii. Sovremennye tekhnologii v meditsine. 2010;(1–2):35–36. (In Russ.).
4. Мikurov A. A., Garbuzenko D. V. Sravnitel’nyy analiz urovnya endotoksemii u bol’nykh tsirrozom pecheni s portal’noy gipertenziyey. Fundamental’nyye issledovaniya. 2011;(6):126–128. (In Russ.).
5. Maianskii D. N., Visse E., Deker K. Novye rubezhi gepatologii. Novosibirsk, Nauka. 1992:264. (In Russ.).
6. Kotiv B. N., Dzidzava I. I., Kashkin D. P. et al. Lecheniye i profilaktika krovotecheniy iz varikozno rasshirennykh ven u bol’nykh tsirrozom pecheni s sindromom portal’noy gipertenzii. Sovremennye tekhnologii v meditsine. 2010;(1–2):35–36. (In Russ.).
7. Maianskii D. N. Khronicheskoe vospalenie. Moscow, Meditsina. 1991: 272. (In Russ.).
8. Maianskii D. N., Visse E., Deker K. Novye rubezhi gepatologii. Novosibirsk, Nauka. 1992:264. (In Russ.).
9. Dutkevich I. G., Koloskov A. V. Vozmozhnosti transfuzionnoy terapiiv khirurgicheskoy praktike. Vestnik khirurgii imeni I. I. Grekova. 2014; 173(2):92–99. (In Russ.).
10. Maianskii D. N. Khronicheskoe vospalenie. Moscow, Meditsina. 1991: 272. (In Russ.).
11. Schiff E. R., Sorrell M. F., Maddrey W. C. Bolezni pecheni po Shiffu. Tsirroz pecheni i ego oslozhneniya. Transplantatsiya pecheni. Мoscow, GEOTAR-Media. 2014:592. (In Russ.).
12. Dutkevich I. G., Koloskov A. V. Vozmozhnosti transfuzionnoy terapiiv khirurgicheskoy praktike. Vestnik khirurgii imeni I. I. Grekova. 2014; 173(2):92–99. (In Russ.).
13. Aisina R. B., Mukhametova L. I. Struktura i funktsii sistemy plazminogen/plasmin. Bioorganicheskaia khimiia. 2014;40(6):590–605. (In Russ.).
14. Schiff E. R., Sorrell M. F., Maddrey W. C. Bolezni pecheni po Shiffu. Tsirroz pecheni i ego oslozhneniya. Transplantatsiya pecheni. Мoscow, GEOTAR-Media. 2014:592. (In Russ.).
15. Grishina E.I. Eykazanoidy i kallikrein-kininovaya sistema pri khronicheskikh gepatitakh i tsirrozakh pecheni. Avtoreferat dissertatsii … kandidata meditsinskikh nauk. Khar’kov. 1991:28. (In Russ.).
16. Aisina R. B., Mukhametova L. I. Struktura i funktsii sistemy plazminogen/plasmin. Bioorganicheskaia khimiia. 2014;40(6):590–605. (In Russ.).
17. Yarovaya G. A., Neshkova A. E. Kallikrein-kininovaya sistema. Proshloye i nastoyashcheye. (K 90-letiyu otkrytiya sistemy). Bioorganicheskaya khimiya. 2015;41(3):275–291. (In Russ.).
18. Grishina E.I. Eykazanoidy i kallikrein-kininovaya sistema pri khronicheskikh gepatitakh i tsirrozakh pecheni. Avtoreferat dissertatsii … kandidata meditsinskikh nauk. Khar’kov. 1991:28. (In Russ.).
19. Dmitriev V. V. Prakticheskie voprosy klinicheskoi koaguologii. Minsk, Belaruskaia navuka. 2017:278. (In Russ.).
20. Yarovaya G. A., Neshkova A. E. Kallikrein-kininovaya sistema. Proshloye i nastoyashcheye. (K 90-letiyu otkrytiya sistemy). Bioorganicheskaya khimiya. 2015;41(3):275–291. (In Russ.).
21. Shiffman D. F. Patofiziologiia krovi. Moscow, Binom. 2017:448. (In Russ.).
22. Dmitriev V. V. Prakticheskie voprosy klinicheskoi koaguologii. Minsk, Belaruskaia navuka. 2017:278. (In Russ.).
23. Waisman D. M. Plasminogen: Structure, Activation and Regulation. Boston, Springer. 2003:318.
24. Shiffman D. F. Patofiziologiia krovi. Moscow, Binom. 2017:448. (In Russ.).
25. Byshevskii A. Sh., Karpova I. A., Poliakova V. A. Vnutrisosudistoe svertyvanie krovi, koaguloaktivnost’ trombotsitov i tolerantnost’ k trombinu. Moscow, Infra-M. 2017:68. (In Russ.).
26. Waisman D. M. Plasminogen: Structure, Activation and Regulation. Boston, Springer. 2003:318.
27. Safonova M. V., Kozlova I. V., Novosel’tsev A. G. Anemiya pri khronicheskikh diffuznykh zabolevaniyakh pecheni. Kazanskiy meditsinskiy zhurnal. 2011;92(6):883–887. (In Russ.).
28. Byshevskii A. Sh., Karpova I. A., Poliakova V. A. Vnutrisosudistoe svertyvanie krovi, koaguloaktivnost’ trombotsitov i tolerantnost’ k trombinu. Moscow, Infra-M. 2017:68. (In Russ.).
29. Bogdanov A. N., Mazurov V. I. Zhelezodefitsitnyye anemii v klinicheskoy praktike. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova. 2009;1(3):71–75. (In Russ.).
30. Safonova M. V., Kozlova I. V., Novosel’tsev A. G. Anemiya pri khronicheskikh diffuznykh zabolevaniyakh pecheni. Kazanskiy meditsinskiy zhurnal. 2011;92(6):883–887. (In Russ.).
31. Onoprienko L. V. Molekuliarnye mekhanizmy reguliatsii aktivnosti makrofagov. Bioorganicheskaia khimiia. 2011;37(4):437–451. (In Russ.).
32. Bogdanov A. N., Mazurov V. I. Zhelezodefitsitnyye anemii v klinicheskoy praktike. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova. 2009;1(3):71–75. (In Russ.).
33. Taganovich A. D., Oletskii E. I., Kotovich I. L. Patologicheskaia biokhimiia. Moscow, Binom. 2016:448. (In Russ.).
34. Onoprienko L. V. Molekuliarnye mekhanizmy reguliatsii aktivnosti makrofagov. Bioorganicheskaia khimiia. 2011;37(4):437–451. (In Russ.).
35. Lukina E. A., Dezhenkova A. V. Metabolizm zheleza v norme i pri patologii. Klinicheskaya onkogematologiya. 2015;8(4):355–361. (In Russ.).
36. Taganovich A. D., Oletskii E. I., Kotovich I. L. Patologicheskaia biokhimiia. Moscow, Binom. 2016:448. (In Russ.).
37. Smirnov O. A. Zhelezo-reguliatornyi gormon pecheni geptsidin i ego mesto v sisteme vrozhdennogo immuniteta. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2010;(5):10–15. (In Russ.).
38. Lukina E. A., Dezhenkova A. V. Metabolizm zheleza v norme i pri patologii. Klinicheskaya onkogematologiya. 2015;8(4):355–361. (In Russ.).
39. Ganz T. Is TfR2 the iron sensor? Blood. 2004;104(13):3839–3840.
40. Smirnov O. A. Zhelezo-reguliatornyi gormon pecheni geptsidin i ego mesto v sisteme vrozhdennogo immuniteta. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2010;(5):10–15. (In Russ.).
41. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–788.
42. Ganz T. Is TfR2 the iron sensor? Blood. 2004;104(13):3839–3840.
43. Rivera S., Ganz T. Hepcidin is the principle mediator of anemia of inflammation. Chest. 2005;128(4):149–150.
44. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–788.
45. Smirnov O. A., Anichkov N. M., Radchenko V. G. Gemosideroz pecheni pri khronicheskom gepatite. Arkhivy patologii. 2003;65(1):39–42. (In Russ.).
46. Rivera S., Ganz T. Hepcidin is the principle mediator of anemia of inflammation. Chest. 2005;128(4):149–150.
47. Umerova A. R. Sindrom endogennoy intoksikatsii pri khronicheskikh gepatitakh i tsirrozakh pecheni. Patogenez, diagnostika, lecheniye. Аvtoreferat dissertatsii … doktora meditsinskikh nauk. Astrakhan’. 2010:36. (In Russ.).
48. Smirnov O. A., Anichkov N. M., Radchenko V. G. Gemosideroz pecheni pri khronicheskom gepatite. Arkhivy patologii. 2003;65(1):39–42. (In Russ.).
49. Pankov R., Yamada K. M. Fibronectin at a glance. Journal of cell science. 2002;115:3861–3863.
50. Umerova A. R. Sindrom endogennoy intoksikatsii pri khronicheskikh gepatitakh i tsirrozakh pecheni. Patogenez, diagnostika, lecheniye. Аvtoreferat dissertatsii … doktora meditsinskikh nauk. Astrakhan’. 2010:36. (In Russ.).
51. Moretti F. A., Chauhan A. K , Iaconcig A. et al. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem. 2007;282(38):28057–28062.
52. Pankov R., Yamada K. M. Fibronectin at a glance. Journal of cell science. 2002;115:3861–3863.
53. Chiang H. Y., Korshunov V. A., Serour A. et al. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29:1074–1079.
54. Moretti F. A., Chauhan A. K , Iaconcig A. et al. A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem. 2007;282(38):28057–28062.
55. Mosher D. F. Fibronectin and liver disease. Hepatology. 1986;6(6):1419–1421.
56. Chiang H. Y., Korshunov V. A., Serour A. et al. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29:1074–1079.
57. Richards P. S., Saba Т. M. Effect of endotoxin on fibronectin and kupffer cell activity. Hepatology. 1985;5(1):32–37.
58. Mosher D. F. Fibronectin and liver disease. Hepatology. 1986;6(6):1419–1421.
59. Grieco A., Matera А., Rocco P. Di et al. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease. Hepatogastroenterology. 1998;45(23):1731–1736.
60. Richards P. S., Saba Т. M. Effect of endotoxin on fibronectin and kupffer cell activity. Hepatology. 1985;5(1):32–37.
61. Iagoda A. V., Koroi P. V. Trombotsitarnye disfunktsii i vozmozhnosti ikh differentsirovannoi korrektsii pri khronicheskom virusnom gepatite. Klinicheskaia meditsina. 2004;(10):41–45. (In Russ.).
62. Grieco A., Matera А., Rocco P. Di et al. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease. Hepatogastroenterology. 1998;45(23):1731–1736.
63. Homoncik M., Ferlitsch A., Ferenci P. et al. Short- and longterm effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand
64. Iagoda A. V., Koroi P. V. Trombotsitarnye disfunktsii i vozmozhnosti ikh differentsirovannoi korrektsii pri khronicheskom virusnom gepatite. Klinicheskaia meditsina. 2004;(10):41–45. (In Russ.).
65. factor release in patients with chronic hepatitis C. AP&T. 2005; 21(1):49–55.
66. Homoncik M., Ferlitsch A., Ferenci P. et al. Short- and longterm effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand
67. Kawasaki Т. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94(7):1918–1922.
68. factor release in patients with chronic hepatitis C. AP&T. 2005; 21(1):49–55.
69. Koroi P. V. Rol’ trombotsitov v realizatsii gemorragicheskogo sindroma pri khronicheskoi patologii pecheni. Kubanskii nauchnyi meditsinskii vestnik. 2009;110(5):40–43. (In Russ.).
70. Kawasaki Т. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94(7):1918–1922.
71. Shcherbak S. G., Kamilova T. A., Lisovets D. G. et al. Geneticheskii polimorfizm sistemy gemostaza. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova. 2015;7(4):66–75. (In Russ.).
72. Koroi P. V. Rol’ trombotsitov v realizatsii gemorragicheskogo sindroma pri khronicheskoi patologii pecheni. Kubanskii nauchnyi meditsinskii vestnik. 2009;110(5):40–43. (In Russ.).
73. Mazurov A. V. Fiziologiia i patologiia trombotsitov. Moscow, Litterra. 2011:480. (In Russ.).
74. Shcherbak S. G., Kamilova T. A., Lisovets D. G. et al. Geneticheskii polimorfizm sistemy gemostaza. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova. 2015;7(4):66–75. (In Russ.).
75. Mamtseva G. I. Funktsional’naya aktivnost’ trombotsitov i granulotsitov donorskoy krovi v usloviyakh izbiratel’nogo udaleniya iz neye fibronektina. Moscow. 1990:25. (In Russ.).
76. Mazurov A. V. Fiziologiia i patologiia trombotsitov. Moscow, Litterra. 2011:480. (In Russ.).
77. Mamtseva G. I. Funktsional’naya aktivnost’ trombotsitov i granulotsitov donorskoy krovi v usloviyakh izbiratel’nogo udaleniya iz neye fibronektina. Moscow. 1990:25. (In Russ.).
Review
For citations:
Lazareva E.I., Koloskov A.V. Potential of transfusion therapy in surgical practice in patients with liver cirrhosis (review of the literature). Grekov's Bulletin of Surgery. 2019;178(4):76-80. (In Russ.) https://doi.org/10.24884/0042-4625-2019-178-4-76-80
Views:
649
Email this article 